On Tuesday, Molina Healthcare earned an upgrade to its Relative Strength (RS) Rating, from 62 to 74.
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains tend to have an RS Rating of over 80 in the early stages of their moves. See if Molina Healthcare can continue to show renewed price strength and hit that benchmark.
Can You Really Time The Stock Market?
Molina Healthcare is trying to complete a cup with handle with a 338.33 entry. See if the stock can break out in heavy trading.
Molina Healthcare showed 15% EPS growth in the latest quarterly report. Sales rose 16%. Look for the next report on or around Apr. 23.
Molina Healthcare holds the No. 2 rank among its peers in the Medical-Managed Care industry group. Cigna Group is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
